Department of Health Policy Archives
Nov. 19, 2015—Use of opioid analgesics is associated with an increased risk of hospitalization for serious infections among patients with rheumatoid arthritis, according to a Vanderbilt study published in Arthritis & Rheumatology.
Oct. 29, 2015—Michael Porter, Ph.D., MBA, of Harvard Business School, a leading authority on organizational strategy, spoke recently at the Owen Graduate School of Management during the opening session of the First Annual Value-based Health Care Delivery Seminar.
Oct. 20, 2015—A “bundle” of electronically implemented care guidelines reduced intensive care unit patient complications related to mechanical ventilation.
Jun. 29, 2015—Stephen Patrick, M.D., MPH, assistant professor of Pediatrics and Health Policy in the Division of Neonatology with the Monroe Carell Jr. Children’s Hospital at Vanderbilt, recently testified before congress about the rise in neonatal abstinence syndrome.
May. 28, 2015—As health care organizations implement new strategies to improve quality and reduce costs, a physician researcher at VUMC is setting out to identify whether there could be unintended effects.
Vanderbilt study finds babies exposed to narcotic pain relievers more likely to experience drug withdrawal syndrome
Apr. 13, 2015—Legally prescribed narcotics taken during pregnancy can lead to neonatal abstinence syndrome, especially in combination with tobacco or SSRIs.
Apr. 2, 2015—Humility, persuasion and a good sense of timing are essential for translating health policy research into real world practice that actually improves the health of Americans, according to former Tennessee Governor Phil Bredesen.
Jan. 15, 2015—Tennessee must improve the health of its citizens if it wants to offer an attractive workforce to businesses, Vanderbilt Chancellor Nicholas S. Zeppos said during a Nashville Community Health Forum attended by state legislators and other stakeholders.
Oct. 30, 2014—One way to lower overall health care costs and lessen health disparities among the poor may be to allow public and private health insurers to incentivize patient adherence to evidence-based protocols for chronic diseases and conditions.